USPS Expands Electric Vehicle Fleet as Nationwide Transition Accelerates 
Tesla Expands Affordable Model 3 Lineup in Europe to Boost EV Demand 
Rio Tinto Raises 2025 Copper Output Outlook as Oyu Tolgoi Expansion Accelerates 
Australia’s Economic Growth Slows in Q3 Despite Strong Investment Activity 
Europe Confronts Rising Competitive Pressure as China Accelerates Export-Led Growth 
Airbus Faces Pressure After November Deliveries Dip Amid Industrial Setback 
Dollar Holds Steady as Markets Shift Focus to 2026 Rate Cut Expectations 
EU Prepares Antitrust Probe Into Meta’s AI Integration on WhatsApp 
Oil Prices Rise as Ukraine Targets Russian Energy Infrastructure 
GM Issues Recall for 2026 Chevrolet Silverado Trucks Over Missing Owner Manuals 
Visa to Move European Headquarters to London’s Canary Wharf 
Asian Currencies Steady as Rupee Hits Record Low Amid Fed Rate Cut Bets 
European Oil & Gas Stocks Face 2026 With Cautious Outlook Amid Valuation Pressure 
Asian Currencies Edge Higher as Markets Look to Fed Rate Cut; Rupee Steadies Near Record Lows 
Airline Loyalty Programs Face New Uncertainty as Visa–Mastercard Fee Settlement Evolves 
China Urged to Prioritize Economy Over Territorial Ambitions, Says Taiwan’s President Lai 
BOJ Governor Ueda Highlights Uncertainty Over Future Interest Rate Hikes 
Moderna appointed Jorge Gomez as its new chief financial officer in April, and it was revealed that he also left his position just two days into the role. The American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, announced this week that its CFO is leaving immediately.
It is not clear if Gomez was fired or if he resigned from his post as the newly-appointed CFO at Moderna. But it was reported that his departure is related to Dentsply Sirona Inc.’s ongoing internal financial probe. The said company was Gomez’s former employer, and it recently disclosed the investigation.
“The Audit Committee is also investigating allegations that certain former and current members of senior management directed the company’s use of these incentives and other actions to achieve executive compensation targets in 2021,” New York Post quoted Dentsply as stating in a filing.
According to Fox Business, the probe is focused on the dental equipment and supplies manufacturing company’s utilization of incentives to sell its dental products to distributors. The investigation covers the sales for the third and fourth quarters of 2021.
Investigators are checking if those incentives were properly accounted for and if those sales were disclosed in periodic reports to the U.S. Securities and Exchange Commission (SEC). Since Gomez has worked in Dentsply Sirona’s financial unit, so there is a possibility that he could also be investigated; thus, he left Moderna not long after being named as its CFO.
“Today announced that its recently appointed Chief Financial Officer, Jorge Gomez, has departed the Company, effective immediately,” Moderna stated in a press release. “The announcement follows the May 10 public disclosure by Mr. Gomez's former employer, Dentsply Sirona Inc., of an ongoing internal investigation into certain matters, including financial reporting.”
Moderna also announced that Davide Meline would continue his work as the company’s CFO following Gomez’s exit. It was reported that Gomez will still get his 12 months' salary which is said to be $700,000 in total, and Consolidated Omnibus Budget Reconciliation Act (COBRA) coverage for one year. Then again, he will be forfeiting his signing bonus and eligibility for relocation reimbursements.
